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of EBM would argue that high quality evidence
obtained through clinical epidemiologic methods
should be ignored in the context of patient care. Nor
would anyone argue that the current best evidence
should be conscientiously, explicitly, and judiciously
utilized when caring for an individual patient.
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Popular, scientific, and medical culture in the United
States favor the rhetoric of a dichotomous “all or
nothing” response to a subject. Proponents of
Evidence-Based Medicine (EBM) have taken this
approach and have pushed for the abandonment of
“authority-based” medicine in favor of EBM.
Unfortunately, rhetoric rarely reflects reality and
nowhere is this truer than in clinical practice in the
Emergency Department (ED). While Dr. Fee and I
agree in theory that EBM should be incorporated more
into clinical practice, we disagree about the current
overall effectiveness of EBM within the ED.
The scope and depth of research underlying EBM is
unable to generate “pure” evidence-based clinical
guidelines on even the most well studied clinical
questions. Most of us would agree with Dr. Fee when
he quotes the Evidence-Based Medicine Working
Group, “all medical action of diagnosis, prognosis,
and therapy should rely on solid quantitative evidence
based on the best of clinical epidemiological research.”
Certainly, clinical guidelines, which grade the level of
evidence supporting recommendations, allow the
integration of the results of multiple randomized studies.
It is important, however, to realize two things about
these guidelines. First, many of these clinical guidelines
contain recommendations that are based on expert
consensus opinion, not evidence, as in the class 1C
(C stands for consensus) recommendation from the
AHA on treating acute coronary syndromes with
nitrates and morphine.1,2 While I agree with Dr. Fee’s
statement, “there are simply too many questions and
too many variables to control to realistically expect a
RCT to be available to answer every clinically relevant
issue,” let’s not call this “pure” EBM.
Secondly, the majority of clinical decisions made in
the ED don’t even approach this level of evidence. At
best, most of our decisions would only be supported
by 3D recommendations (Dr. Fee’s table) or AHA
class 2A/B evidence. EBM, as it currently stands, is
unable to consistently and appropriately evaluate and
integrate evidence from studies other than randomized
clinical trials; however, these studies underpin the
majority of clinical decisions within the ED.
Furthermore, since the complete set of relevant
variables for any clinical condition is unknown, the
evidence underlying EBM continues to evolve and
change over time. For example, prior to 1997 the
majority of trials investigating myocardial ischemia
were done on middle-aged white men and suggested
that “crushing substernal chest pain” was the primary
presenting symptom; however, Goldberg et al. and
subsequent investigators have shown that the
presenting symptoms for angina in women are
substantially different.3,4 In fact, in some studies only
43% of women report having chest pain and in most
studies the predominant presenting symptom is
dyspnea.4 While cardiac disease is very well studied,
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EBM not only failed to appreciate all of the significant
variables which are important in evaluating patients in
the ED, but also may have inappropriately excluded
patients from randomized controlled trials on
myocardial ischemia prior to 1997. Clinician
preconceptions will always be part of EBM, just as
they are part of “authority-based” medicine, and as a
result the evidence (and best evidence-based practice)
will continue to evolve.
In fact the number of variables not examined due to
perceived patient compliance, drug cost, funding
sources, etc., is so extensive as to make EBM difficult
to currently translate into actual clinical practice. So
while it is clear that antibiotics are not required in
housed compliant patients with a low grade fever and
bronchitis, it is not clear that the evidence
demonstrates they are not required in the same patient
who is a homeless alcoholic. Similarly, is single dose
azithromycin or 7 days of levofloxacin to treat
community-acquired pneumonia superior to 7 days
of doxycycline? There is no randomized controlled
trial comparing either expensive drug with the
relatively cheap doxycycline, because there is no
monetary incentive to fund such a study. Yet somehow
there are a plethora of “evidence-based” clinical
guidelines on the treatment of community-acquired
pneumonia using all three of these agents. In the end,
competent clinicians need to meld relevant EBM with
their clinical experience andcommon sense to form
an appropriate care plan for the individual patient.
I suspect that the areas of agreement for Dr. Fee and
I are greater than our disagreements; however, we do
have some areas of significant philosophical
disagreement. Clearly EBM is a powerful tool to
improve clinical care and outcomes within the
Emergency Department; however, I believe the
problems currently inherent within EBM demand a
continued integration of pathophysiology, anatomy,
common sense and clinical experience. Randomized
controlled trials can provide elegant answers to narrow
clinical questions within narrow subsets of the
population, but the answers are difficult to translate
to more heterogeneous populations or complex
problems. In fact, when specialty societies attempt to
answer more general questions with treatment
guidelines and ranked evidence, they are often forced
to rely on consensus or “authority-based”
recommendations. There is nothing wrong with
integrating EBM and older “authority-based” teachings
and then molding the treatment to fit the individual
patient. That is in fact “good clinical practice,” but it is
not EBM and shouldn’t be called that.
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